Skip to content

Sulodexide

DRUG16 trials

Sponsors

Keryx Biopharmaceuticals, University of Iowa, Corbridge Group Philippines, Inc., Ajou University School of Medicine, Bama GeVe, S.L.U.

Conditions

AnticoagulantCOVID-19Chronic Kidney DiseaseCovid19Dense Deposit DiseaseDiabetic NephropathyDiabetic Nephropathy Type 2Diabetic Retinopathy

Phase 1

Phase 2

Phase 3

Effect of Sulodexide in Early Diabetic Nephropathy
CompletedNCT00130208
Keryx BiopharmaceuticalsDiabetic Nephropathy
Start: 2005-08-31End: 2008-02-29Updated: 2018-03-23
Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
TerminatedNCT00462202
Keryx BiopharmaceuticalsDiabetic Nephropathy
Start: 2007-04-30End: 2008-03-31Updated: 2017-03-03
The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney Disease
NCT01000545
Corbridge Group Philippines, Inc.Chronic Kidney Disease
Start: 2009-11-30End: 2012-12-31Target: 1508Updated: 2009-10-30
Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone
NCT03370705
Alfa Wassermann TunisiaPeripheral Arterial Obstructive Disease
Start: 2019-01-31End: 2020-03-30Target: 156Updated: 2019-12-02
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
RecruitingNCT04257487
Arianna Anticoagulazione FoundationAnticoagulant, Elderly, Venous Thromboembolism
Start: 2020-12-21End: 2027-01-02Target: 1455Updated: 2024-07-31
Endothelial Protection in Post COVID-19 Patients With Sulodexide
CompletedNCT05371925
Centro Medico del NoroesteEndothelial Dysfunction, Post COVID-19, Thrombosis
Start: 2023-06-01End: 2024-04-19Updated: 2024-08-09
Sulodexide in Controlling the Recurrence of Psoriasis
Enrolling by invitationNCT06982196
Xijing HospitalPsoriasis (PsO), Randomised Controlled Trial
Start: 2025-04-20End: 2027-12-31Target: 160Updated: 2025-05-21

Phase 4

Unknown Phase

Related Papers